LEADER |
01976nam a22002537a 4500 |
001 |
1641499 |
041 |
|
|
|a eng
|
044 |
|
|
|b ليبيا
|
100 |
|
|
|9 478684
|a Ben Rabha, Fatma M.
|e Author
|
245 |
|
|
|a Mechanistic Studies on Aziridinyl-Benzoquinones in Cultured Tumour Cells
|
260 |
|
|
|b جامعة المرقب - كلية الآداب والعلوم بمسلاته
|c 2017
|g يونيو
|
300 |
|
|
|a 690 - 712
|
336 |
|
|
|a بحوث ومقالات
|b Article
|
520 |
|
|
|b This study compares the anti tumour effects of the novel NQO1 activated drug RH1 (2, 5-diaziridinyl-3 -hydoxymethyl-6-methyl-1, 4- benzoquinone) with a novel lipophilic ester derivative Es5 on the isogenic cell lines MDA 468 and MDA 468 NQO1 which differs only in expression of wtNQO1. A 39- fold enhancement of growth inhibitory activity was seen in NQO1 expressing cells compared the NQO1 null cells for the Es5 compared to the 25- fold increase seen for the parent drug, RH1. The kinetics of cell cycle arrest, apoptosis are different in the NQO1 expressing and null cell lines. This indicates a different mechanism of activations and/ or activity for these agents in the presence of active NQO1 protein. We show that Es5 has a higher partition coefficient than RH1, which may enable Es5 to enter the brain. Following cleavage of the ester group Es5 produces a Quinone whose cytoxicity profile is comparable to RH1.
|
653 |
|
|
|a زراعة الأورام
|a الأدوية المنشطة
|a خلايا الأورام
|
700 |
|
|
|9 478685
|a Elashheb, Mabruka S.
|e Co-Author
|
700 |
|
|
|9 711066
|a Saeed, Nagat M.
|e Co-Author
|
700 |
|
|
|9 33453
|a Hassan, Samia Abd Alkarim Ali
|e Co-Author
|
700 |
|
|
|9 711067
|a Ben Saad, Lamees A.
|e Co-Author
|
773 |
|
|
|4 العلوم الإنسانية ، متعددة التخصصات
|6 Humanities, Multidisciplinary
|c 027
|e Alqala Journal
|l 007
|m ع7
|o 1878
|s مجلة القلعة
|v 000
|
856 |
|
|
|u 1878-000-007-027.pdf
|
930 |
|
|
|d y
|p y
|
995 |
|
|
|a HumanIndex
|
999 |
|
|
|c 891630
|d 891630
|